Biomarker Expression in Multifocal Vulvar High-Grade Squamous Intraepithelial Lesions.
Thuijs NB, Schonck WAM, Klaver LLJ, Fons G, van Beurden M, Steenbergen RDM, Bleeker MCG.
Cancers (Basel). 2021 Nov 11;13(22):5646. doi: 10.3390/cancers13225646.
Circulating Hsa-miR-431-5p as Potential Biomarker for Squamous Cell Vulvar Carcinoma and Its Premalignant Lesions.
Bujko M, Zalewski K, Szczyrek M, Kowalik A, Boresowicz J, Długosz A, Goryca K, Góźdź S, Kowalewska M.
Diagnostics (Basel). 2021 Sep 17;11(9):1706. doi: 10.3390/diagnostics11091706.
Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3).
Madeleine MM, Johnson LG, Doody DR, Tipton ER, Carter JJ, Galloway DA.
J Low Genit Tract Dis. 2016 Jul;20(3):257-60. doi: 10.1097/LGT.0000000000000227.
Gynecological cancers and the global COVID-19 pandemic.
Alkatout I, Karimi-Zarchi M, Allahqoli L.
J Turk Ger Gynecol Assoc. 2020 Dec 4;21(4):272-278. doi: 10.4274/jtgga.galenos.2020.2020.0119.
Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: a tissue microarray study.
Samartzis N, Imesch P, Dedes KJ, Samartzis EP, Fedier A, Fink D, Caduff R, Fehr MK.
BMC Cancer. 2011 Oct 26;11:463. doi: 10.1186/1471-2407-11-463.
Risk factors for unrecognized invasive carcinoma in patients with vulvar high-grade squamous intraepithelial lesion at vulvoscopy-directed biopsy.
Preti M, Bucchi L, Ghiringhello B, Privitera S, Frau V, Corvetto E, Benedetto C, Micheletti L.
J Gynecol Oncol. 2017 Jul;28(4):e27. doi: 10.3802/jgo.2017.28.e27.
Therapeutic Assessment of Vulvar Squamous Intraepithelial Lesions with CO2 Laser Vaporization in Immunosuppressed Patients.
Ribalta JCL, Mateussi MV, Speck NMG.
Rev Bras Ginecol Obstet. 2018 Jan;40(1):26-31. doi: 10.1055/s-0037-1618573. Epub 2018 Jan 16.
DNA methylation and copy number alterations in the progression of HPV-associated high-grade vulvar intraepithelial lesion.
Runello F, Jary A, Duin S, Kim Y, van Eer K, Voss FO, Thuijs NB, Bleeker MCG, Steenbergen RDM.
Int J Cancer. 2025 May 15;156(10):1926-1935. doi: 10.1002/ijc.35366. Epub 2025 Feb 12.
Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
Hildesheim A, Han CL, Brinton LA, Kurman RJ, Schiller JT.
Obstet Gynecol. 1997 Nov;90(5):748-54. doi: 10.1016/S0029-7844(97)00467-5.
Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinoma.
Castelnau-Marchand P, Escande A, Mazeron R, Bentivegna E, Cavalcanti A, Gouy S, Baratiny C, Maroun P, Morice P, Haie-Meder C, Chargari C.
Brachytherapy. 2017 May-Jun;16(3):518-525. doi: 10.1016/j.brachy.2017.01.005. Epub 2017 Mar 3.
